Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $57 | $103 | $98 | $75 |
| - Cash | $6 | $7 | $12 | $12 |
| + Debt | $36 | $35 | $36 | $36 |
| Enterprise Value | $87 | $131 | $122 | $99 |
| Revenue | $21 | $22 | $24 | $21 |
| % Growth | -2.5% | -6.8% | 12.3% | – |
| Gross Profit | $9 | $10 | $10 | $9 |
| % Margin | 40.5% | 47.6% | 42.9% | 44% |
| EBITDA | -$2 | $5 | $6 | $5 |
| % Margin | -10.5% | 22.5% | 24.9% | 24.9% |
| Net Income | -$3 | $2 | $1 | $2 |
| % Margin | -16.2% | 10.9% | 4.4% | 10.9% |
| EPS Diluted | -7.82 | 5.38 | 2.35 | 5.09 |
| % Growth | -245.4% | 128.9% | -53.8% | – |
| Operating Cash Flow | $3 | $2 | $4 | $2 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$3 |
| Free Cash Flow | $2 | $1 | $2 | -$0 |